Magnetoencephalography in Children

ConditionsEpilepsy Intracranial Tumors Cerebrovascular Disease Autism ADHD - Attention Deficit Disorder With Hyperactivity Neuropsychiatric Disorders Tic Disorder, Childhood Mental Retardation Developmental Disabilities

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age1-18

SponsorChildren's Hospital of Fudan University

About this trial

This study is a single-center observational clinical study, which evaluates the diagnostic value of magnetoencephalography (MEG) in the diagnosis of neurodevelopmental diseases in children, such as the localization of epileptic foci and brain functional areas, intracranial tumors, cerebrovascular diseases, autism, mental retardation, and neuropsychiatric disorders.

Eligibility criteria

Qualifiers

aged 1 month-18 years old (date of investigate minus date of birth)

epilepsy

intracranial tumors

cerebrovascular diseases

Disqualifiers

None

Trial design

Treatments tested in this trial

Magnetoencephalography

Treatment groups

1,500 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Children's Hospital of Fudan University

Lead sponsor

Source ClinicalTrials.gov